Semaglutide patients had: 7.7 lbs (3.5 kg) more weight loss than placebo (with a 1 mg injection dose) 5.7 lbs (2.6 kg) more weight loss than placebo (with a 0.5 mg injection dose) Ozempic injection helped with weight loss and weight loss maintenance when used with diet and exercise in clinical trials, however, it is not FDA-approved for weight loss
None of these questions are reasons to avoid the category
Location: Can appear anywhere on the body, but most commonly on the face, back, and shoulders
Early clinical studies in Barth syndrome, primary mitochondrial myopathies, and age-related macular degeneration have shown favorable safety, tolerability, and signals of efficacy (Thompson et al., 2024)
Clinical trials and studies have shown that skin-related side effects, although not very common, can occur in some individuals using semaglutide
ALC helps transport fatty acids into mitochondria the powerhouses of your cells